225 related articles for article (PubMed ID: 15316755)
1. Early plasmacytoid dendritic cell leukemia/lymphoma coexpressing myeloid antigenes.
Giagounidis AA; Heinsch M; Haase S; Aul C
Ann Hematol; 2004 Nov; 83(11):716-21. PubMed ID: 15316755
[TBL] [Abstract][Full Text] [Related]
2. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of immunophenotype and leukemia associated immunophenotype in 610 patients with acute myeloid leukemia].
Liu YR; Wang YZ; Chen SS; Chang Y; Fu JY; Li LD; Wang H; Yu H; Jiang B; Huang XJ
Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):731-6. PubMed ID: 18457262
[TBL] [Abstract][Full Text] [Related]
4. Clinical Characteristics and Diagnosis of Acute Myeloid Leukemia with CD56-Blastic Plasmacytoid Dendritic Cell Neoplasm.
Zhang X; Wu Y; Li C; Shen K; Li R
Clin Lab; 2023 Jun; 69(6):. PubMed ID: 37307129
[TBL] [Abstract][Full Text] [Related]
5. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia.
Zeleznikova T; Stevulova L; Kovarikova A; Babusikova O
Neoplasma; 2007; 54(6):471-7. PubMed ID: 17949229
[TBL] [Abstract][Full Text] [Related]
6. Acute myeloid leukemia possibly producing thrombopoietic factor(s).
Fujita A; Matsuoka M; Shimonaka Y; Imai N; Asano S
Jpn J Clin Oncol; 1993 Dec; 23(6):366-72. PubMed ID: 7506802
[TBL] [Abstract][Full Text] [Related]
7. Immunophenotypic pattern of myeloid populations by flow cytometry analysis.
Gorczyca W; Sun ZY; Cronin W; Li X; Mau S; Tugulea S
Methods Cell Biol; 2011; 103():221-66. PubMed ID: 21722806
[TBL] [Abstract][Full Text] [Related]
8. Plasmacytoid dendritic cell leukemia in children.
Hama A; Kudo K; Itzel BV; Muramatsu H; Nishio N; Yoshida N; Takahashi Y; Yagasaki H; Ito M; Kojima S
J Pediatr Hematol Oncol; 2009 May; 31(5):339-43. PubMed ID: 19415013
[TBL] [Abstract][Full Text] [Related]
9. CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia.
Khoury JD; Medeiros LJ; Manning JT; Sulak LE; Bueso-Ramos C; Jones D
Cancer; 2002 May; 94(9):2401-8. PubMed ID: 12015765
[TBL] [Abstract][Full Text] [Related]
10. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry.
Rezaei A; Adib M; Mokarian F; Tebianian M; Nassiri R
Med Sci Monit; 2003 Aug; 9(8):CR359-62. PubMed ID: 12942032
[TBL] [Abstract][Full Text] [Related]
11. Unrelated donor bone marrow transplantation for acute mixed lineage (myeloid and B-lymphoid lineage) leukemia in an adult with Down syndrome.
Takagi K; Yoshida A; Kinoshita K; Iwashima D; Imamaura S; Iwasaki H; Tsutani H; Ueda T
Ann Hematol; 2003 Apr; 82(4):236-40. PubMed ID: 12707727
[TBL] [Abstract][Full Text] [Related]
12. Extensive flow cytometric characterization of plasmacytoid dendritic cell leukemia cells.
Gopcsa L; Banyai A; Jakab K; Kormos L; Tamaska J; Matolcsy A; Gogolak P; Rajnavolgyi E; Paloczi K
Eur J Haematol; 2005 Oct; 75(4):346-51. PubMed ID: 16146542
[TBL] [Abstract][Full Text] [Related]
13. An unusual case of cutaneous blastic plasmacytoid dendritic cell neoplasm with concomitant B-cell lymphoproliferative disorder.
Patel JL; Shetty S; Salama ME
Am J Dermatopathol; 2011 May; 33(3):e31-6. PubMed ID: 20861710
[TBL] [Abstract][Full Text] [Related]
14. [Sustained remission of blastic plasmacytoid dendritic cell neoplasm with ABVD chemotherapy].
Tanikawa S; Sakuranaka H; Chong JM; Okada Y; Takimoto M
Rinsho Ketsueki; 2012 Feb; 53(2):246-51. PubMed ID: 22450587
[TBL] [Abstract][Full Text] [Related]
15. CD4+ CD56+ lineage negative malignancies: a new entity developed from malignant early plasmacytoid dendritic cells.
Jacob MC; Chaperot L; Mossuz P; Feuillard J; Valensi F; Leroux D; Béné MC; Bensa JC; Brière F; Plumas J
Haematologica; 2003 Aug; 88(8):941-55. PubMed ID: 12935983
[TBL] [Abstract][Full Text] [Related]
16. Therapy-related myeloid neoplasm in an 18-year-old boy with B-lymphoblastic leukemia.
Qing X; Panosyan E; Yue C; Ji P; Gotesman M; French S; Cai J
Exp Mol Pathol; 2017 Dec; 103(3):263-266. PubMed ID: 29155023
[TBL] [Abstract][Full Text] [Related]
17. Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: results from the Hellenic Dendritic Cell Leukemia Study Group.
Tsagarakis NJ; Kentrou NA; Papadimitriou KA; Pagoni M; Kokkini G; Papadaki H; Pappa V; Marinakis T; Anagnostopoulos NI; Vadikolia C; Anagnostopoulos A; Angelopoulou MK; Terpos E; Poziopoulos C; Anargyrou K; Rontogianni D; Papadaki T; Psarra A; Kontopidou FN; Skoumi D; Papadhimitriou SI; Paterakis G;
Leuk Res; 2010 Apr; 34(4):438-46. PubMed ID: 19793612
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
Plesa C; Chelghoum Y; Plesa A; Elhamri M; Tigaud I; Michallet M; Dumontet C; Thomas X
Cancer; 2008 Feb; 112(3):572-80. PubMed ID: 18085638
[TBL] [Abstract][Full Text] [Related]
19. CD4+/CD56+ hematodermic neoplasm ("blastic natural killer cell lymphoma"): neoplastic cells express the immature dendritic cell marker BDCA-2 and produce interferon.
Pilichowska ME; Fleming MD; Pinkus JL; Pinkus GS
Am J Clin Pathol; 2007 Sep; 128(3):445-53. PubMed ID: 17709319
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic quantitative features of patients with acute myeloid leukemia.
Pereira FG; Metze K; Costa FP; Lima CS; Lorand-Metze I
Neoplasma; 2006; 53(2):155-60. PubMed ID: 16575472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
